<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Obesity Market on FinanClub</title>
    <link>https://finan.club/tags/obesity-market/</link>
    <description>Recent content in Obesity Market on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Tue, 16 Jan 2024 09:05:48 +0000</lastBuildDate><atom:link href="https://finan.club/tags/obesity-market/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>PFE</title>
      <link>https://finan.club/us/pfe/</link>
      <pubDate>Tue, 16 Jan 2024 09:05:48 +0000</pubDate>
      
      <guid>https://finan.club/us/pfe/</guid>
      <description>score:53
Chances: Pfizer&amp;rsquo;s work in developing new drugs and breaking into the obesity market shows potential for future growth and innovation. Pharmaceutical executives are plotting to break into the lucrative obesity market, indicating a potential opportunity for Pfizer to expand its product portfolio.</description>
    </item>
    
  </channel>
</rss>
